Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medmira Inc (MIR.VN)

Medmira Inc (MIR.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 52,630
  • Shares Outstanding, K 701,731
  • Annual Sales, $ 433 K
  • Annual Income, $ -2,676 K
  • 60-Month Beta 0.43
  • Price/Sales 128.34
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MIR.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings $0.00 on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.070 +7.14%
on 04/19/24
0.090 -16.67%
on 04/12/24
-0.015 (-16.67%)
since 03/22/24
3-Month
0.070 +7.14%
on 04/19/24
0.105 -28.57%
on 02/16/24
-0.025 (-25.00%)
since 01/22/24
52-Week
0.070 +7.14%
on 04/19/24
0.135 -44.44%
on 12/15/23
-0.035 (-31.82%)
since 04/21/23

Most Recent Stories

More News
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis

Maternova, Inc. , accelerating advances in maternal and infant health through innovative, accessible solutions, and MedMira Inc. (TSXV: MIR), a developer and manufacturer of rapid diagnostics, today...

MIR.VN : 0.075 (unch)
MedMira Strengthens and Expands Board

HALIFAX, Nova Scotia, July 14, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the appointment of Ms. Pascale Nini to the...

MIR.VN : 0.075 (unch)
MedMira Reports Third Quarter Results FY2022

HALIFAX, Nova Scotia, June 29, 2022 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended...

MIR.VN : 0.075 (unch)
MedMira Receives Patent for its Unique Quantitative Diagnostic System

HALIFAX, Nova Scotia, June 06, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a U.S. patent...

MIR.VN : 0.075 (unch)
MedMira provides an update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market

HALIFAX, Nova Scotia, May 27, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on its regulatory progress in Europe...

MIR.VN : 0.075 (unch)
VYRAâ„¢ Product Line Update

HALIFAX, Nova Scotia, May 20, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) provides an update on the Company’s regulatory work for...

MIR.VN : 0.075 (unch)
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test

HALIFAX, Nova Scotia, May 12, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the achievement of another milestone in its...

MIR.VN : 0.075 (unch)
MedMira receives the CE mark for its Reveal® TP (Syphilis) and starts clinical trials in Canada

HALIFAX, Nova Scotia, March 09, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) launches its Reveal® TP (Syphilis) product in Europe...

MIR.VN : 0.075 (unch)
MedMira Receives CE Marking for its REVEALCOVID-19® PLUS Total Antibody Test

HALIFAX, Nova Scotia, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) has received the CE mark for its REVEALCOVID-19® PLUS...

MIR.VN : 0.075 (unch)
MedMira Provides a Pre-Annual General Meeting Update

HALIFAX, Nova Scotia, Feb. 04, 2022 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) provides a pre-Annual General Meeting (AGM) update on...

MIR.VN : 0.075 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which...

See More

Key Turning Points

3rd Resistance Point 0.075
2nd Resistance Point 0.075
1st Resistance Point 0.075
Last Price 0.075
1st Support Level 0.075
2nd Support Level 0.075
3rd Support Level 0.075

See More

52-Week High 0.135
Fibonacci 61.8% 0.110
Fibonacci 50% 0.103
Fibonacci 38.2% 0.095
Last Price 0.075
52-Week Low 0.070

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar